United States · FDA National Drug Code directory
Ruconest
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71274-350_a742815a-7705-9153-e053-2995a90a562d
- Product NDC
- 71274-350
- Form
- INJECTION, POWDER, FOR SOLUTION
- Composition / generic term
- c1 esterase inhibitor recombinant
- Labeler
- Pharming Healthcare Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20180401
- Source listing expiry
- 20261231
Source-listed ingredients
- CONESTAT ALFA — 2100 U/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-USE in 1 CARTON (71274-350-02) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-USE (71274-350-01) · 71274-350-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →